Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking about sex after menopause: can counseling boost satisfaction?

NCT ID NCT07283146

Symptom relief Sponsor: NESLİHAN YILMAZ SEZER Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a special type of sexual counseling, called the EX-PLISSIT model, could improve sexual quality of life, satisfaction, and perceptions in postmenopausal women. 74 women under 65 who were naturally postmenopausal and married took part. The counseling involved sessions focused on permission, information, and specific suggestions. The goal was to see if this approach helps women feel better about their sexuality during menopause.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EX-PLISSIT model-based sexual counseling
What this could lead to
If effective, this counseling approach could help postmenopausal women improve their sexual well-being and quality of life.
What could go wrong
This is a small, completed study with 74 participants, so results may not apply to all women. The intervention is counseling, not a drug, so effects may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

74 people

The number who actually took part.

Started

Dec 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Postmenopausal, defined as having had no menstrual periods or vaginal bleeding in the last 12 months, * Under 65 years of age, * Married, * Having entered menopause naturally, * Able to understand, speak, and read Turkish. Exclusion Criteria: * Women with diagnosed conditions that may significantly affect sexual quality of life (such as diabetes, hypertension, heart disease, pulmonary diseases, cancer types, psychiatric disorders, or a history of neurological stroke), * Women using medications known to negatively affect sexual function (including psychotropic drugs, cardiac and antihypertensive medications, anticonvulsants, opioids, antinarcotics, H2-receptor antagonists, and antihistamines), * Those who have previously received or are currently receiving hormone replacement therapy, * Those with a diagnosis of sexual dysfunction in themselves or their partners, * Those who have experienced major stressful life events (such as an accident, trauma, or the death or severe illness of a close relative) within the three months prior to the study, * Women with a serious impairment that affects their ability to complete data collection forms, * Not willing to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postmenopause are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postmenopause

Contacts and locations

Locations

  • Akdagmadeni Public Education Center

    Yozgat, 66300, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.